Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
52,031,274
-
Share change
-
+21,169,657
-
Total reported value
-
$431,687,084
-
Put/Call ratio
-
90%
-
Price per share
-
$8.30
-
Number of holders
-
121
-
Value change
-
+$177,526,274
-
Number of buys
-
84
-
Number of sells
-
30
Institutional Holders of SYNERGY PHARMACEUTICALS DEL - COM NEW (SGYPQ) as of Q2 2015
As of 30 Jun 2015,
SYNERGY PHARMACEUTICALS DEL - COM NEW (SGYPQ) was held by
121 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,031,274 shares.
The largest 10 holders included
PAULSON & CO. INC., VANGUARD GROUP INC, BlackRock Fund Advisors, ORBIMED ADVISORS LLC, Invesco Ltd., MILLENNIUM MANAGEMENT LLC, BlackRock Institutional Trust Company, N.A., GREAT POINT PARTNERS LLC, FRANKLIN RESOURCES INC, and York Capital Management Global Advisors, LLC.
This page lists
121
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.